E
Lyell Immunopharma, Inc. LYEL
$0.5854 -$0.0209-3.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Total Cash And Short-Term Investments 370.53M 440.55M 491.12M 526.30M 546.22M
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses 9.07M 9.50M 8.71M 7.87M 8.46M
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets 379.59M 450.05M 499.82M 534.17M 554.69M

Total Current Assets 379.59M 450.05M 499.82M 534.17M 554.69M
Net Property, Plant & Equipment 72.94M 124.71M 130.79M 136.53M 142.32M
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 6.31M 5.35M 4.53M 4.52M 4.52M
Total Assets 490.86M 619.22M 654.14M 694.22M 750.03M

Total Accounts Payable 5.37M 3.60M 4.20M 4.90M 4.82M
Total Accrued Expenses 29.37M 21.88M 18.77M 18.25M 20.36M
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current 7.97M 7.13M 6.90M 6.67M 6.27M
Total Finance Division Other Current Liabilities 11.08M 907.00K 1.01M 2.54M 3.07M
Total Other Current Liabilities 11.08M 907.00K 1.01M 2.54M 3.07M
Total Current Liabilities 53.79M 33.51M 30.88M 32.35M 34.52M

Total Current Liabilities 53.79M 33.51M 30.88M 32.35M 34.52M
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases 50.99M 51.44M 53.32M 55.16M 56.89M
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities 3.25M 3.57M 3.44M 3.55M 3.66M
Total Liabilities 108.04M 88.52M 87.64M 91.06M 95.08M

Common Stock & APIC 1.73B 1.68B 1.68B 1.67B 1.66B
Retained Earnings -1.35B -1.15B -1.11B -1.06B -1.00B
Treasury Stock & Other 291.00K 760.00K -397.00K -404.00K -94.00K
Total Common Equity 382.82M 530.70M 566.50M 603.16M 654.95M

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 382.82M 530.70M 566.50M 603.16M 654.95M
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 382.82M 530.70M 566.50M 603.16M 654.95M

Weiss Ratings